POY_1170x120_8-12-19

Off-Patent Drugs

NCPA urges more scrutiny of generic drug pricing

NCPA urges more scrutiny of generic drug pricing

ALEXANDRIA, Va. — In tandem with a congressional hearing, the National Community Pharmacists Association called on lawmakers to take a closer look at recent generic drug price hikes and their impact on patients and community pharmacists. On Wednesday, the Senate Special Committee on Aging held a hearing titled “Sudden Price Spikes in Off-Patent Drugs: Perspectives